Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services

Journal of Substance Abuse Treatment

Volumn 33, Issue 1, 2007, Pages 85-90

  Whitley, Susan D ^a   Kunins, Hillary V ^a   Arnsten, Julia H ^a   Gourevitch, Marc N ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buprenorphine; Chemical dependency; Drug users; Methadone; Opioid dependence

Indexed keywords

BUPRENORPHINE; LEVACETYLMETHADOL; METHADONE; NALOXONE; OPIATE; ACETYLMETHADOL; NARCOTIC AGENT;

ADDICTION; ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG USE; EMPLOYMENT; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; METHADONE TREATMENT; OUTPATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; TREATMENT OUTCOME; AMBULATORY CARE; COUNSELING; HEALTH CARE DELIVERY; INTEGRATED HEALTH CARE SYSTEM; MIDDLE AGED; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATIENT; PATIENT CARE; SOCIAL WORK; SUBSTANCE ABUSE; UNITED STATES;

ADULT; AMBULATORY CARE; BUPRENORPHINE; COUNSELING; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; METHADONE; METHADYL ACETATE; MIDDLE AGED; NALOXONE; NARCOTICS; NEW YORK CITY; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PATIENT DROPOUTS; SOCIAL WORK; SUBSTANCE ABUSE DETECTION;

EID: 35248821874     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.11.003     Document Type: Article

References (21)

1. Agosti V., Nunes E., and Ocepeck-Welikson K. Patient factors related to early attrition from an outpatient cocaine research clinic. American Journal of Drug and Alcohol Abuse 22 (1996) 29-39
2. Alford D.P., Compton P., and Samet J.H. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Annals of Internal Medicine 144 (2006) 127-134
3. Ball J.C., and Ross A. The effectiveness of methadone maintenance treatment (1991), Springer-Verlag, New York
4. Bickel W.K., Amass L., Higgins S.T., Badger G.J., and Esch R.A. Effects of adding behavioral treatment to opiate detoxification with buprenorphine. Journal of Consulting and Clinical Psychology 65 (1997) 803-810
5. Bridge T.P., Fudala P.J., Herbert S., and Leiderman D.B. Safety and health policy considerations related to the use of buprenorphine/naloxone as and office-based treatment for opiate dependence. Drug and Alcohol Dependence 70 (2003) S79-S85
6. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., and Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry 54 (1997) 71-80
7. Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction: Treatment improvement protocol (TIP) Series 40 (2004), Substance Abuse and Mental Health Administration, Rockville, MD
8. Fiellin D.A., and O'Connor P.G. New federal initiatives to enhance the medical treatment of opioid dependence. Annals of Internal Medicine 137 (2002) 688-692
9. Fiellin D.A., and O'Connor P.G. Office-based treatment of opioid-dependent patients. New England Journal of Medicine 347 (2002) 817-823
10. Fiellin D.A., Pantalon M.V., Chawarski M.C., Moore B.A., Sullivan L.E., O'Connor P.G., et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. New England Journal of Medicine 355 (2006) 365-374
11. Hoffman J.A., Landry M.J., and Caudill B.D. Living in balance: A comprehensive substance abuse treatment and relapse prevention manual (2003), Hazelden Publishing and Educational Services, Center City, MN
12. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., and Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine 343 (2000) 1290-1297
13. Kidorf M., Disney E.R., King V.L., Neufeld K., Beilenson P.L., and Brooner R.K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug and Alcohol Dependence 74 (2004) 115-122
14. Ling W., and Wesson D.R. Clinical efficacy of buprenorphine: Comparisons to methadone and placebo. Drug and Alcohol Dependence 70 (2003) S49-S57
15. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., and O'Brien C.P. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association 269 (1993) 1953-1959
16. New York State Office of Alcoholism and Substance Abuse Services. Guidelines for level of care determination: Level of care for alcohol and drug treatment referral (LOCADTR) 2.0 (2001) (2001), Office of Alcoholism and Substance Abuse Services, Albany, NY
17. Stein M.D., Cioe P., and Friedmann P.D. Buprenorphine retention in primary care. Journal of General Internal Medicine 20 (2005) 1038-1041
18. Strain E.C., Stitzer M.L., Liebson I.A., and Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology 16 (1996) 58-67
19. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2004 national survey on drug use and health, NSDUH Series H-28, DHHS Publication No. SMA 05-4062 (2005), Substance Abuse and Mental Health Services Administration, Rockville, MD
20. Sullivan L.E., Chawarski M., O'Connor P.G., Schottenfeld R.S., and Fiellin D.A. The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?. Drug and Alcohol Dependence 79 (2005) 113-116
21. Wesson D.R., and Ling W. The clinical opiate withdrawal scale (COWS). Journal of Psychoactive Drugs 35 (2003) 253-259